Joanne Jeter: Clinical Trials

1 trial sponsored by Joanne Jeter, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Withdrawn 1
Phase 21Withdrawn 1

Follow Joanne Jeter: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pembrolizumab and Imatinib in Patients With Locally Advanced/Metastatic Melanoma With c-KIT Mutation/Amplification
Imatinib Mesylate, Laboratory Biomarker Analysis, Pembrolizumab - Stage IIIA Skin Melanoma, Stage IIIB Skin Melanoma
Phase 1 / Phase 2WithdrawnJoanne Jeter2016-11-042018-04-05

Conditions studied

Melanoma (1)

Interventions

Imatinib Mesylate (1)  ·  pembrolizumab (1)

NIH funding

P30CA016058 (1)